Tenax Therapeutics, Inc.
Clinical trials sponsored by Tenax Therapeutics, Inc., explained in plain language.
-
New pill aims to help heart failure patients breathe easier and walk farther
Disease control Recruiting nowThis phase 3 study tests an oral drug called levosimendan in 540 adults with pulmonary hypertension and heart failure with preserved ejection fraction. Participants receive either the drug or a placebo to see if it improves their 6-minute walking distance and heart failure sympto…
Phase: PHASE3 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New pill aims to boost exercise ability in heart-lung condition
Disease control Recruiting nowThis study tests an oral medication called levosimendan in 230 adults with pulmonary hypertension and a type of heart failure where the heart pumps normally but is stiff. The main goal is to see if the drug helps people walk farther in six minutes compared to a placebo. Participa…
Phase: PHASE3 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC